Status:
UNKNOWN
Are Corneal Epithelial Defects Related to Changes in Ocular Bacterial Flora in Patients With ANLDO
Lead Sponsor:
Western Galilee Hospital-Nahariya
Conditions:
Acquired Nasolacrimal Duct Obstruction
Eligibility:
All Genders
18+ years
Brief Summary
Comparison between patients with nasolacrimal duct obstruction and healthy patients and the influence of their bacterial flora on the corneal epithelium.
Detailed Description
Any patient with nasolacrimal duct obstruction above the age of 18 Comparing changes in their bacterial ocular flora to healthy patients without obstruction and above 18 years of age
Eligibility Criteria
Inclusion
- 18 years of age or older, nasolacrimal duct obstruction
Exclusion
- younger then 18 years of age
- ocular infections
- patients after repair of lacrimal duct surgery
- systemic active diseases
- patients taking medication that are know to influence bacterial flora of the eye
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02234700
Start Date
August 1 2014
End Date
February 1 2015
Last Update
September 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Galileeh Hospital
Naharya, Israel, 22402